Prospective study of the long-term efficacy and safety of lansoprazole in patients with the Zollinger-Ellison syndrome-Reference-Cited by-同舟云学术

Prospective study of the long-term efficacy and safety of lansoprazole in patients with the Zollinger-Ellison syndrome

Published:2007-03-31 Issue: Volume:7 Page:41-50
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

JENSEN R. T.,METZ D. C.,KOVIACK P. D.,FEIGENBAUM K. M.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.1993.tb00588.x/fullpdf

Reference39 articles.

1. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas;Zollinger;Ann Surg,1955

2. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states;Jensen;Am J Med,1984

3. Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: A prospective study;Maton;Gastroenterology,1988

4. Reflux esophagitis in patients with Zollinger-Ellison syndrome;Miller;Gastroenterology,1990

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Proton Pump Inhibitor–Acid Suppressive Treatment Can Cause Vitamin B12 Deficiency in Zollinger–Ellison Syndrome (ZES) Patients;International Journal of Molecular Sciences;2024-07-02

2. Successful Lifetime/Long-Term Medical Treatment of Acid Hypersecretion in Zollinger-Ellison Syndrome (ZES): Myth or Fact? Insights from an Analysis of Results of NIH Long-Term Prospective Studies of ZES;Cancers;2023-02-21

3. Gastric Epithelial Cell Modality and Proton Pump Inhibitor;Journal of Clinical Biochemistry and Nutrition;2008

4. Consequences of Long-Term Proton Pump Blockade: Insights from Studies of Patients with Gastrinomas;Basic Clinical Pharmacology Toxicology;2006-01

5. AN OVERVIEW OF THE PHARMACOLOGY, EFFICACY, SAFETY AND COST‐EFFECTIVENESS OF LANSOPRAZOLE;International Journal of Clinical Practice;2002-03